Welcome to LookChem.com Sign In|Join Free

CAS

  • or

154992-24-2

Post Buying Request

154992-24-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

154992-24-2 Usage

Description

Different sources of media describe the Description of 154992-24-2 differently. You can refer to the following data:
1. RU-58841 is a non-steroidal antiandrogen that binds to the androgen receptor (Kd = 1.8, 1.1, 5.6, 1.3, and 1.4 nM for human, rat, mouse, hamster prostate, and hamster flank organ receptors, respectively). In vivo, topical administration of RU-58841 (1-100 μg per animal) reduces size of the flank organ withoutaffecting sex organs in a dose-dependent manner in hamsters. It has no effect on sex organ weight in intact rats when administered percutaneously, subcutaneously, or orally at doses up to 1 mg per animal. RU-58841 (5% v/v) also induces hair regrowth in the bald frontal scalps of postpubertal stumptailed macaques, a model for male pattern baldness.
2. RU-58841 is a non-steroidal antiandrogen that binds to the androgen receptor (Kd = 1.8, 1.1, 5.6, 1.3, and 1.4 nM for human, rat, mouse, hamster prostate, and hamster flank organ receptors, respectively). In vivo, topical administration of RU-58841 (1-100 μg per animal) reduces size of the flank organ without affecting sex organs in a dose-dependent manner in hamsters. It has no effect on sex organ weight in intact rats when administered percutaneously, subcutaneously, or orally at doses up to 1 mg per animal. RU-58841 (5% v/v) also induces hair regrowth in the bald frontal scalps of postpubertal stumptailed macaques, a model for male pattern baldness.

Androgen receptor

RU 58841 (PSK-3841) is a specific androgen receptor antagonist or anti-androgen. RU 58841 (PSK-3841) has a dramatic effect on hair regrowth. Androgen receptor (AR) is a type of nuclear receptor that is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone in the cytoplasm and then translocating into the nucleus. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. The androgen receptor is most closely related to the progesterone receptor, and progestins in higher dosages can block the androgen receptor. The main function of the androgen receptor is as a DNA-binding transcription factor that regulates gene expression. Androgen regulated genes are critical for the development and maintenance of the male sexual phenotype. Mutations in this gene are also associated with complete androgen insensitivity (CAIS).

Uses

Different sources of media describe the Uses of 154992-24-2 differently. You can refer to the following data:
1. RU58841 (Roussel Uclaf) is a nonsteroidal topical antiandrogen without significant systemic effects apparently due to its metabolism in the skin. This appears to be a promising new hair growth agent that promotes hair growth on the scalp as well as retards hair growth of both beard and body hair follicles. RU58841 has produced highly efficacious results in stumptailed macaques. The synergistic effects of RU58841 and minoxidil topical solution (2% and 5%) have also been reported in stumptailed macaques. The effect of combined treatment was most remarkable early on, but by 1 year no significant benefit of combined treatment was apparent relative to either treatment alone.
2. Avoid hair loss: RU58841 is a non-steroidal antiandrogenic medication that was initially developed in the 1980s as a topical treatment remedy for acne and male pattern baldness – androgenetic alopecia.
3. RU 58841, is a specific androgen receptor antagonist or anti-androgen, that has shown to have effect on hair growth.

Laboratory Procedures

RU-58841 is supplied as a crystalline solid. A stock solution may be made by dissolving the RU-58841 in the solvent of choice. RU-58841 is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF), which should be purged with an inert gas. The solubility of RU-58841 is approximately33 mg/ml in ethanol and DMF and approximately 25 mg/ml in DMSO. RU-58841 is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, RU-58841 should first be dissolved in ethanol and then diluted with the aqueous buffer of choice. RU-58841 has a solubility of approximately 0.16 mg/ml in a 1:5 solution of ethanol:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day.

Side effects

Since RU58841 has not passed into phase two of drug development, there are literally no studies that have highlighted the side effects of this medication specifically. Pharmacologically speaking, there are absolutely no pharmacologic products that are 100% free of side effects. Like with every medication, RU58841 also affects each individual differently. But based on the physiologic processes it undergoes, we can hypothesize on some of its potential side effects. For instance, you should be aware that RU58841 does not only block DHT but all other androgens including testosterone.

References

Battmann, T., Bonfils, A., Branche, C., et al. RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J. Steroid Biochem. Mol. Biol. 48(1), 55-60 (1994). Obana, N., Chang, C., and Uno, H. Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque. Endocrinology138(1), 356-361 (1997).

Preparation

RU58841 is active against baldness and is commercially available. The previously reported synthesis uses phosgene, three discrete inert atmosphere steps and three steps that require flash chromatography. Our synthesis uses no phosgene, only one inert atmosphere step and does not require flash chromatography. Alternative synthesis of the anti-baldness compound RU58841

Synthesis Reference(s)

A bromine–nitro substitution at tertiary carbon and using 2-nitropropane as leaving group enable a short phosgene-free synthesis of RU58841.pubs.rsc.org

Check Digit Verification of cas no

The CAS Registry Mumber 154992-24-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,9,9 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 154992-24:
(8*1)+(7*5)+(6*4)+(5*9)+(4*9)+(3*2)+(2*2)+(1*4)=162
162 % 10 = 2
So 154992-24-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3

154992-24-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

1.2 Other means of identification

Product number -
Other names 4-(3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:154992-24-2 SDS

154992-24-2Synthetic route

4-Bromobutyl acetate
4753-59-7

4-Bromobutyl acetate

4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
143782-20-1

4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Stage #1: 4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile With sodium hydride In N,N-dimethyl-formamide; mineral oil for 0.25h;
Stage #2: 4-Bromobutyl acetate In N,N-dimethyl-formamide; mineral oil at 50℃; for 2h;
80%
toluene ethanol

toluene ethanol

4-Bromobutyl acetate
4753-59-7

4-Bromobutyl acetate

4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
143782-20-1

4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
In N-methyl-acetamide; methanol; ethanol; dichloromethane; water
4-amino-2-trifluoromethylbenzonitrile
654-70-6

4-amino-2-trifluoromethylbenzonitrile

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: potassium carbonate / 1,2-dichloro-ethane / 14 h / 20 °C
2.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
3.1: iron; hydrogenchloride / isopropyl alcohol; ethanol; water / 1 h / 90 °C
4.1: potassium carbonate / 1,2-dichloro-ethane / 14 h
5.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
6.1: N,N-dimethyl-formamide / 7 h / 110 °C
7.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 0.25 h
7.2: 2 h / 50 °C
View Scheme
2-bromo-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methylpropanamide
1259327-69-9

2-bromo-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methylpropanamide

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
2.1: iron; hydrogenchloride / isopropyl alcohol; ethanol; water / 1 h / 90 °C
3.1: potassium carbonate / 1,2-dichloro-ethane / 14 h
4.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
5.1: N,N-dimethyl-formamide / 7 h / 110 °C
6.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 0.25 h
6.2: 2 h / 50 °C
View Scheme
N-[4-cyano-3-(tri-fluoromethyl)phenyl]-2-methyl-2-nitropropanamide

N-[4-cyano-3-(tri-fluoromethyl)phenyl]-2-methyl-2-nitropropanamide

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: iron; hydrogenchloride / isopropyl alcohol; ethanol; water / 1 h / 90 °C
2.1: potassium carbonate / 1,2-dichloro-ethane / 14 h
3.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
4.1: N,N-dimethyl-formamide / 7 h / 110 °C
5.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 0.25 h
5.2: 2 h / 50 °C
View Scheme
2-amino-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methylpropanamide
208122-09-2

2-amino-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methylpropanamide

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium carbonate / 1,2-dichloro-ethane / 14 h
2.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
3.1: N,N-dimethyl-formamide / 7 h / 110 °C
4.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 0.25 h
4.2: 2 h / 50 °C
View Scheme
2-bromo-N-(1-{[4-cyano-3-(trifluoromethyl)phenyl]carbamoyl}-1-methylethyl)-2-methylpropanamide

2-bromo-N-(1-{[4-cyano-3-(trifluoromethyl)phenyl]carbamoyl}-1-methylethyl)-2-methylpropanamide

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium nitrite / N,N-dimethyl-formamide / 14 h / 20 °C
2.1: N,N-dimethyl-formamide / 7 h / 110 °C
3.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 0.25 h
3.2: 2 h / 50 °C
View Scheme
tetradecanoyl chloride
112-64-1

tetradecanoyl chloride

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

RU 58841-myristate

RU 58841-myristate

Conditions
ConditionsYield
With triethylamine In chloroform for 24h;55.2%
1H-imidazole
288-32-4

1H-imidazole

sodium thiosulfate

sodium thiosulfate

triphenylphosphine
603-35-0

triphenylphosphine

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

4-(4,4-dimethyl-2,5-dioxo-3-(4-iodobutyl)-1-imidazolidinyl)-2-(trifluoromethyl)-benzonitrile
192805-64-4

4-(4,4-dimethyl-2,5-dioxo-3-(4-iodobutyl)-1-imidazolidinyl)-2-(trifluoromethyl)-benzonitrile

Conditions
ConditionsYield
With iodine In dichloromethane
water+ice

water+ice

isopropyl chloroformate
108-23-6

isopropyl chloroformate

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

bis-2-propyl carbonate
6482-34-4

bis-2-propyl carbonate

Conditions
ConditionsYield
With 2-(Dimethylamino)pyridine; sodium chloride In pyridine; toluene
4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
154992-24-2

4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

cyclohexyl chloroformate
13248-54-9

cyclohexyl chloroformate

dicyclohexyl carbonate
4427-97-8

dicyclohexyl carbonate

Conditions
ConditionsYield
With pyridine; dmap

154992-24-2Relevant articles and documents

Alternative synthesis of the anti-baldness compound RU58841

Leonard, Matthew J.,Lingham, Anthony R.,Niere, Julie O.,Jackson, Neale R. C.,McKay, Peter G.,Huegel, Helmut M.

, p. 14143 - 14148 (2014/04/17)

RU58841 is active against baldness and is commercially available. The previously reported synthesis uses phosgene, three discrete inert atmosphere steps and three steps that require flash chromatography. Our synthesis uses no phosgene, only one inert atmosphere step and does not require flash chromatography. This is achieved by stepwise construction of the hydantoin moiety around the amino group of 3-trifluoromethyl-4-cyanoaniline and ring closure to give a 2-nitropropane leaving group. On a small scale we achieved an overall yield of 33%.

Phenylimidazolidine preparation process

-

, (2008/06/13)

A subject of the invention is a preparation process for the products of formula (I): STR1 in which R1 and R2 represent in particular hydrogen, cyano, halogen or amino,R3 represents in particular hydrogen or hydroxyl alkyl, R4 and R5 represent in particular optionally substituted alkyl, X and y represent oxygen or sulphur, characterized in that a product of formula (A): STR2 is prepared in which W represents a halogen atom or a hydantoin derivative, which is subjected to various reactions in order to obtain the products of formula (I), all their isomers and their salts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 154992-24-2